Correction: Ixekizumab Demonstrates Rapid and Consistent Efficacy for Patients with Psoriatic Arthritis, Regardless of Psoriasis Severity(Dermatology and Therapy, (2024), 14, (1615-1631), 10.1007/s13555-024-01188-y)
Publication
, Journal Article
Armstrong, AW; Jaleel, T; Merola, JF; Gottlieb, AB; Khattri, S; Helt, CC; Malatestinic, WN; Ross, SE; Ngantcha, ME; de Vlam, K
Published in: Dermatology and Therapy
August 1, 2024
The Introduction section of abstract is missing the word ‘severe’ and hence the corrected sentence should read as, “This post hoc analysis reports musculoskeletal, skin, and nail outcomes through week 24 in patients from SPIRIT-P1 and SPIRIT-P2, stratified by mild, moderate, or severe psoriasis at baseline”.
Duke Scholars
Published In
Dermatology and Therapy
DOI
EISSN
2190-9172
ISSN
2193-8210
Publication Date
August 1, 2024
Volume
14
Issue
8
Start / End Page
2297
Related Subject Headings
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Armstrong, A. W., Jaleel, T., Merola, J. F., Gottlieb, A. B., Khattri, S., Helt, C. C., … de Vlam, K. (2024). Correction: Ixekizumab Demonstrates Rapid and Consistent Efficacy for Patients with Psoriatic Arthritis, Regardless of Psoriasis Severity(Dermatology and Therapy, (2024), 14, (1615-1631), 10.1007/s13555-024-01188-y). Dermatology and Therapy, 14(8), 2297. https://doi.org/10.1007/s13555-024-01221-0
Armstrong, A. W., T. Jaleel, J. F. Merola, A. B. Gottlieb, S. Khattri, C. C. Helt, W. N. Malatestinic, S. E. Ross, M. E. Ngantcha, and K. de Vlam. “Correction: Ixekizumab Demonstrates Rapid and Consistent Efficacy for Patients with Psoriatic Arthritis, Regardless of Psoriasis Severity(Dermatology and Therapy, (2024), 14, (1615-1631), 10.1007/s13555-024-01188-y).” Dermatology and Therapy 14, no. 8 (August 1, 2024): 2297. https://doi.org/10.1007/s13555-024-01221-0.
Armstrong AW, Jaleel T, Merola JF, Gottlieb AB, Khattri S, Helt CC, et al. Correction: Ixekizumab Demonstrates Rapid and Consistent Efficacy for Patients with Psoriatic Arthritis, Regardless of Psoriasis Severity(Dermatology and Therapy, (2024), 14, (1615-1631), 10.1007/s13555-024-01188-y). Dermatology and Therapy. 2024 Aug 1;14(8):2297.
Armstrong, A. W., et al. “Correction: Ixekizumab Demonstrates Rapid and Consistent Efficacy for Patients with Psoriatic Arthritis, Regardless of Psoriasis Severity(Dermatology and Therapy, (2024), 14, (1615-1631), 10.1007/s13555-024-01188-y).” Dermatology and Therapy, vol. 14, no. 8, Aug. 2024, p. 2297. Scopus, doi:10.1007/s13555-024-01221-0.
Armstrong AW, Jaleel T, Merola JF, Gottlieb AB, Khattri S, Helt CC, Malatestinic WN, Ross SE, Ngantcha ME, de Vlam K. Correction: Ixekizumab Demonstrates Rapid and Consistent Efficacy for Patients with Psoriatic Arthritis, Regardless of Psoriasis Severity(Dermatology and Therapy, (2024), 14, (1615-1631), 10.1007/s13555-024-01188-y). Dermatology and Therapy. 2024 Aug 1;14(8):2297.
Published In
Dermatology and Therapy
DOI
EISSN
2190-9172
ISSN
2193-8210
Publication Date
August 1, 2024
Volume
14
Issue
8
Start / End Page
2297
Related Subject Headings
- 3202 Clinical sciences
- 1103 Clinical Sciences